quality of care

Research in Review

Little Difference Between MSUS and DAS28-driven Treatment Strategies for Rheumatoid Arthritis

07/18/2016

JCP Editors

In early rheumatoid arthritis (RA), musculoskeletal ultrasound (MSUS)-driven treat-to-target strategies may led to more intensive treatment than disease activity score in 28 joints (DAS28)-driven strategies, but not...

In...

07/18/2016

Journal of Clinical Pathways

Research in Review

Expectant Management for Prostate Cancer Underutilized at Community Centers

07/15/2016

JCP Editors

A retrospective analysis of hospital trends has shown that the likelihood of receiving expectant management for low-risk prostate cancer was significantly lower in men evaluated at community centers compared with...

A...

07/15/2016

Journal of Clinical Pathways

Research in Review

ESMO Magnitude of Clinical Benefit Scale Aids Cancer Decision-Making

07/14/2016

JCP Editors

A study out of the Medical University of Vienna, Austria, one of Europe’s largest cancer centers, asserts that the European Society for Medical Oncology (ESMO) Magnitude of Clinical Benefit Scale (MCBS) is a reliable...

A...

07/14/2016

Journal of Clinical Pathways

Research in Review

Breast Cancer Treatment May Lead to Functional Decline or Death in Elderly Patients

07/01/2016

JCP Editors

Many older women diagnosed with nonmetastatic breast cancer may experience functional decline or death within 12 months of breast cancer treatment initiation, but the Vulnerable Elders Survey (VES-12) may help to...

Many...

07/01/2016

Journal of Clinical Pathways

Research in Review

Immunotherapeutic Agents May Cause Arthritis

06/24/2016

JCP Editors

Cancer treatment with the immune checkpoint inhibitors nivolumab and ipilimumab may cause patients to develop inflammatory arthritis or sicca syndrome, claims a study conducted by a group of researchers at Johns...

Cancer...

06/24/2016

Journal of Clinical Pathways

Research in Review

Omitting Radiotherapy for Breast Cancer Patients May Lead to Cost Savings

06/20/2016

JCP Editors

Omitting radiotherapy as a part of standard care for women with low-risk luminal A (low-grade, estrogen receptor-positive) breast cancer would produce significant cost savings without adversely affecting outcomes,...

...

06/20/2016

Journal of Clinical Pathways

Editor's Page

Pathways for Improving Quality of Life

06/20/2016

Winston Wong, PharmD, Editor-in-Chief

As early detection of cancers and improved treatments continue to improve outcomes for patients with cancer, care providers have been able to increase their focus on the quality of life for patients with cancer who...

As...

06/20/2016

Journal of Clinical Pathways

Discontinuing Treatment With Nivolumab Does Not Affect Survival in Patients With Melanoma

06/10/2016

JCP Editors

Discontinuing nivolumab-ipilimumab treatment because of adverse events may not have a detrimental impact on survival among patients with advanced melanoma, according to follow-up from a randomized trial presented at...

...

06/10/2016

Journal of Clinical Pathways

Quality Measures for NSCLC Significantly Improve Survival

05/20/2016

JCP Editors

Including certain quality measures as a part of care for patients with non-small cell lung cancer (NSCLC) who undergo surgery can significantly improve survival, according to results presented at the American...

...

05/20/2016

Journal of Clinical Pathways

Research in Review

Algorithm Can Help Reduce Delays in Lung Cancer Evaluation

05/19/2016

JCP Editors

An algorithm designed to identify patients with a risk of cancer in need of follow-up may help to reduce delays in the diagnostic evaluation of abnormal chest imaging results, according to a recent...

An...

05/19/2016

Journal of Clinical Pathways